Fullscript has promoted one of its top executives to the newly created role of president to help steer the company toward its goal of cracking US$1 billion in annual revenues. The Ottawa-based health-care platform announced Monday that Ashley Koch, who joined the firm as chief financial and strategy officer in early 2023, will now also […]
Already a Subscriber? Log in
Get Instant Access to This Article
Become an Ottawa Business Journal Insider and get immediate access to all of our Insider-only content and much more.
Fullscript has promoted one of its top executives to the newly created role of president to help steer the company toward its goal of cracking US$1 billion in annual revenues.
The Ottawa-based health-care platform announced Monday that Ashley Koch, who joined the firm as chief financial and strategy officer in early 2023, will now also serve as president.
The company said in a news release that Koch will work in “close partnership” with CEO Kyle Braatz to “drive Fullscript’s growth and solidify its position as a household name at the forefront of health, technology, and whole-person care.”
The move comes about 18 months after Koch was hired as CFO and chief strategy officer, with Braatz telling Techopia last spring that part of her role would be to pursue potential acquisitions and “strategic investments that change the business into something more dynamic than it is today.”
Fullscript closed a deal two weeks ago to acquire Rupa Health, a 190-person startup headquartered in San Francisco that helps medical practitioners order, track and manage thousands of laboratory tests in a single interface.
It’s the first M&A transaction the Ottawa firm has made since Koch joined its C-suite and comes about two and a half years after Fullscript’s acquisition of New Hampshire-based Emerson Ecologics – a transaction that effectively doubled the company’s revenues to US$600 million.
“I am honoured to take on this new role, working alongside Kyle and the rest of the leadership team in driving Fullscript’s strategic direction,” Koch said in a statement. “The company has experienced impressive growth during my tenure – from the Emerson integration to the acquisition of Rupa – and I look forward to continuing to lead Fullscript on our growth trajectory.”
A graduate of Boston College, Koch brings more than a decade of senior management experience in the U.S. health-care industry.
Before joining Fullscript, Koch served as CFO at Boston-based Shields Health Solutions, which provides specialty pharmacy services such as refrigeration and packaging to about 1,000 hospitals in the U.S. via a network of 80 health system partners. Drugstore giant Walgreens Boots Alliance, which already owned a majority stake in the company, acquired Shields outright in 2022 for US$1.37 billion.
Koch was previously CFO at Steward Medical Group, the largest private equity-backed integrated health system in the U.S. At Steward, she spearheaded a national expansion strategy that saw the company make multiple acquisitions and triple its revenues in a three-year span.
In a statement on Monday, Braatz said Koch’s “track record of success and deep relationships in the sector will be critical as she builds upon her existing role within our leadership team.”
